Cargando…
Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis
BACKGROUND: Desmoid tumours/aggressive fibromatosis (DT/AF) are infrequent soft-tissue neoplasms. They usually behave as indolent diseases. However, they may grow locally infiltrating or compressing adjacent structures. The role of local treatment is limited and only a few drugs have shown activity....
Autores principales: | Martin-Liberal, Juan, Benson, Charlotte, McCarty, Heather, Thway, Khin, Messiou, Christina, Judson, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176486/ https://www.ncbi.nlm.nih.gov/pubmed/24279994 http://dx.doi.org/10.1186/2045-3329-3-13 |
Ejemplares similares
-
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience
por: Maruzzo, Marco, et al.
Publicado: (2015) -
Pazopanib, a promising option for the treatment of aggressive fibromatosis
por: Szucs, Zoltan, et al.
Publicado: (2017) -
Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour)
por: Hong, H, et al.
Publicado: (2011) -
Pazopanib: a novel treatment option for aggressive fibromatosis
por: Bulut, Gulcan, et al.
Publicado: (2016) -
Desmoid-Type Fibromatosis
por: Garcia-Ortega, Dorian Yarih, et al.
Publicado: (2020)